Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Free webinar: Telepathology: is there added value in LMICs?
Free webinar: Telepathology: is there added value in LMICs?

Daratumumab slows progression in refractory multiple myeloma

Prof Palumbo - University of Turin, Turin, Italy
Daratumumab slows progression in refractory multiple myeloma ( Prof Palumbo - University of Turin, Turin, Italy )
6 Jun 2016

Developments in haematological malignancies

Dr Stephen Nimer - University of Miami, Miami, USA
Developments in haematological malignancies ( Dr Stephen Nimer - University of Miami, Miami, USA )
6 Jun 2016

Early integrated palliative care to improve family caregivers outcomes

Dr Areej El-Jawahri - Massachusetts General Hospital, Boston, USA
Early integrated palliative care to improve family caregivers outcomes ( Dr Areej El-Jawahri - Massachusetts General Hospital, Boston, USA )
6 Jun 2016

Recent developments in targeted therapies

Dr Stephen Nimer - University of Miami, Miami, USA
Recent developments in targeted therapies ( Dr Stephen Nimer - University of Miami, Miami, USA )
6 Jun 2016

First results of a prospective bendamustine/rituximab trial in patients with MCL

Dr Mathias Rummel - University of Giessen, Giessen, Germany
First results of a prospective bendamustine/rituximab trial in patients with MCL ( Dr Mathias Rummel - University of Giessen, Giessen, Germany )
6 Jun 2016

Performance characteristics and stage distribution of invasive epithelial ovarian/tubal/peritoneal cancers

Prof Usha Menon - University College London, London, UK
Performance characteristics and stage distribution of invasive epithelial ovarian/tubal/peritoneal cancers ( Prof Usha Menon - University College London, London, UK )
6 Jun 2016

MyPathway guidance of targeted therapy based on molecular profiles

Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA
MyPathway guidance of targeted therapy based on molecular profiles ( Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA )
6 Jun 2016

Testing the safety and efficacy of the PD-L1 antibody durvalumab

Dr Christophe Massard - Institut Gustave Roussy, Paris, France
Testing the safety and efficacy of the PD-L1 antibody durvalumab ( Dr Christophe Massard - Institut Gustave Roussy, Paris, France )
6 Jun 2016

Upfront autologous stem cell transplantation for newly diagnosed multiple myeloma

Prof Michele Cavo - Seràgnoli Institute of Hematology, Bologna, Italy
Upfront autologous stem cell transplantation for newly diagnosed multiple myeloma ( Prof Michele Cavo - Seràgnoli Institute of Hematology, Bologna, Italy )
6 Jun 2016

Subset of anaplastic glioma patients benefit from adjuvant chemo

Dr Martin van den Bent - Erasmus MC Cancer Center, Rotterdam, The Netherlands
Subset of anaplastic glioma patients benefit from adjuvant chemo ( Dr Martin van den Bent - Erasmus MC Cancer Center, Rotterdam, The Netherlands )
6 Jun 2016

ASCO 2016: What is the optimal chemotherapy dosing regimen for prostate cancer?

Prof Charles Ryan and Prof Nick James
ASCO 2016: What is the optimal chemotherapy dosing regimen for prostate cancer? ( Prof Charles Ryan and Prof Nick James )
6 Jun 2016

Advanced RET-rearranged NSCLC

Dr Takashi Seto and Dr Kiyotaka Yoh
Advanced RET-rearranged NSCLC ( Dr Takashi Seto and Dr Kiyotaka Yoh )
6 Jun 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation